Keywords: gsk, urges, nigeria, use, arv, duty, waiver

GSK urges Nigeria to use ARV duty waiver

Article | 19 April 2004

Print This

GlaxoSmithKline has urged the Nigerian government to implement a duty waiver on antiretroviral drugs to improve access to them by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in